AngioDynamics Inc
NASDAQ:ANGO
AngioDynamics Inc
PP&E Net
AngioDynamics Inc
PP&E Net Peer Comparison
Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors
Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
AngioDynamics Inc
NASDAQ:ANGO
|
PP&E Net
$40.9m
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-5%
|
|
Boston Scientific Corp
NYSE:BSX
|
PP&E Net
$3.3B
|
CAGR 3-Years
11%
|
CAGR 5-Years
13%
|
CAGR 10-Years
8%
|
|
Stryker Corp
NYSE:SYK
|
PP&E Net
$3.8B
|
CAGR 3-Years
6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
13%
|
|
Abbott Laboratories
NYSE:ABT
|
PP&E Net
$10.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
PP&E Net
$3.8B
|
CAGR 3-Years
34%
|
CAGR 5-Years
30%
|
CAGR 10-Years
28%
|
|
Shockwave Medical Inc
NASDAQ:SWAV
|
PP&E Net
$113.6m
|
CAGR 3-Years
61%
|
CAGR 5-Years
84%
|
CAGR 10-Years
N/A
|
See Also
What is AngioDynamics Inc's PP&E Net?
PP&E Net
40.9m
USD
Based on the financial report for Feb 29, 2024, AngioDynamics Inc's PP&E Net amounts to 40.9m USD.
What is AngioDynamics Inc's PP&E Net growth rate?
PP&E Net CAGR 10Y
-5%
Over the last year, the PP&E Net growth was -19%. The average annual PP&E Net growth rates for AngioDynamics Inc have been 1% over the past three years , and -5% over the past ten years .